Latest News
Myriad Genetics, Inc.
- Myriad Genetics to present at Wells Fargo healthcare conference
- Myriad Genetics cuts FY26 revenue guidance by $90M, faces securities probe
- Myriad Genetics, Inc. Estimates – NASDAQ:MYGN
- Myriad Genetics presents data on cancer recurrence detection test By Investing.com
- Myriad Genetics to sell off Prenatal Health testing business to Labcorp
- Current ratio of Myriad Genetics, Inc. – XETR:MYD
- Myriad Genetics (MYGN) Stock Trades Up, Here Is Why
- Form 8K Myriad Genetics Inc For: 20 October By Investing.com
- Why is Myriad Genetics stock surging today?
- Myriad Genetics to report Q3FY26 results on November 4, 2026
- Myriad Genetics to report Q3 2026 earnings on N...
- SOPHiA GENETICS, Myriad Genetics and AstraZeneca Collaborate to Advance Precision Oncology in Prostate Cancer
Headlines from the last 30 days, linking to the original publishers. See all market news →